BAU-Drug Design Symposium 2013
Welcome to BAU-Drug Design Symposium 2013
The main theme of the BAU-Drug Design 2013 will be “Recent Developments in Structure- and Ligand-based Drug Design Methodologies,” which will cover a wide range of critically important sessions. This symposium aims to serve as a platform for interaction among renowned experimental and computational scientists from academia and industry to discuss the latest developments in methodology, application and approaches in the drug design field and to accelerate scientific discovery as well as reflect the key goals of the strategic priorities of the university: Integration, inter-disciplinary research on basic health sciences. The key subjects:
High Throughput Screening (HTS) Methods
De Novo Drug Design
As its ninth faculty, the university has opened a Faculty of Medicine, where research is as much a priority as educating students. One priority is addressing a crucial societal issue in Turkey – the need for fundamental work in the basic health sciences extending to investigations that translate from theory and laboratory to clinical work, to the population and society as a whole. Advancing health involves research ranging from the basic life sciences and disease processes at the molecular and genetic level, to health economics, the social determinants of health, and the ethics of health care, to health policy, promotion and delivery. An integral part of the sustainable research direction is in its ability to maintain strength as a research-intensive university by attracting and retaining researchers who will inspire curiosity and creativity in others and by prioritizing the professional development of the future research leaders. To this end, medical research in biocomputing and rational drug design is one among the cornerstone strategies for the university’s research success.
Bu içerik 12/11/2012 tarihinde güncellenmiştir.